Stock screener

CTNM

Conviction 68HealthcareScan · Mon, Jul 20, 2026
CTNM$13.58-4.60%
ResistanceSupportVol 14Insider sell
63 bars
2
2
Vol MA14 348.03K
Apr 20May 6May 26Jun 11Jul 1Jul 20
Contineum Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.contineum-tx.com ↗
Price13.58
Change-4.60%
Gap-0.56%
Rel volume0.82×
Avg volume519.54K
Avg $ vol7.51M
SMA 2014.38
SMA 5013.53
SMA 20012.77
Price vs 50+0.35%
Price vs 200+6.32%
MA stackbullish
50/200 cross—
Supertrendup · 12.16
RSI (14)46
MACD hist-0.18
MACD crossbear · 3d
Stoch %K / %D6 / 16
ADX (14)20
+DI / −DI16 / 17
RSI divergence—
MACD divergence—
ATR %+7.31%
ADR %7.58%
52w high16.39
52w low4.35
From 52w high-17.18%
Above 52w low+212.07%
New 52w highNo
SqueezeOff
Bollinger width33.28%
%B0.33
Donchian pos39.80%
Donchian high16.91
Donchian low11.37
AVWAP (52w high)15.07
vs AVWAP high-9.92%
AVWAP (52w low)12.01
vs AVWAP low+13.04%
OBV trendUp
Chaikin MF (20)0.18
Today vs 20d0.82×
Avg vol (14d)348.02K
Avg vol (20d)519.54K
Avg $ vol (20d)7.51M
Market cap313.57M
RS 3m (vs SPY)+1.06%
RS 6m (vs SPY)+13.34%
RS line new highNo
Trend template8/8
Technical rank68.7
1 week-7.15%
1 month+11.64%
3 months+0.33%
6 months+14.65%
1 year+253.52%
YTD+19.18%
P/E-5.23
P/B1.25
P/S—
P/FCF-5.65
EPS-2.17
Div yield—
ROE-23.99%
ROA-22.95%
Debt/Eq—
Current38.00
EV/EBITDA-4.33
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth-41.93%
Price target21.20
Target upside56.17%
Analyst ratingBuy
Institutional97.26%
Ent. value293.41M
Revenue0
Net income-14.46M
Gross profit—
Free cash flow-55.54M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out32.72M
Employees51
ListedFri, Apr 5, 2024
Free float26.58M
Float %81.2%
Short interest2.14M
Days to cover3.0d
Short volume84.7%
Squeeze score51 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.39 vs −$0.55
Last surprise+29.1% beat
Setup gradeB
Conviction68 / 100
Pattern quality—
Tech rank68.7 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance16.46
Support11.17
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CTNM

All disclosures →
No recent disclosed trades by Congress in CTNM. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CTNM · 4 buys · 6 sells

InsiderSideShares
Lorrain Daniel S.
Chief Scientific Officer · Class A Common Stock · 2026-07-09
Sell25
Lorrain Daniel S.
Chief Scientific Officer · Class A Common Stock · 2026-07-09
Exercise25
Lorrain Daniel S.
Chief Scientific Officer · Stock Option (right to buy) · 2026-07-09
Exercise25
Lorrain Daniel S.
Chief Scientific Officer · Class A Common Stock · 2026-07-08
Sell1.01K
Lorrain Daniel S.
Chief Scientific Officer · Class A Common Stock · 2026-07-08
Exercise1.01K
Lorrain Daniel S.
Chief Scientific Officer · Stock Option (right to buy) · 2026-07-08
Exercise1.01K
Stengone Carmine N.
CEO and President · Class A Common Stock · 2026-07-08
Exercise2.5K
Stengone Carmine N.
CEO and President · Class A Common Stock · 2026-07-08
Sell2.5K
Stengone Carmine N.
CEO and President · Stock Option (right to buy) · 2026-07-08
Exercise2.5K
Schimmelpennink Evert B.
Director · Stock Option (right to buy) · 2026-06-26
Grant19K

SEC filings

EDGAR filings in CTNM · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.